CP
Corvus Pharmaceuticals Inc
🇩🇪XSTU.C17GermanyHealthcare
€11.19EURdown -0.12 (-1.06%)OpenEnd of day7:12 PM
Price€11.19-0.12 (-1.06%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US2210151005
- CUSIP
- Not reported
Company
- Employees
- 37
- Headquarters
- South San Francisco, United States
- Website
- https://www.corvuspharma.com
- CEO
- Dr. Richard A. Miller M.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$54.13M-19.93%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$45.23M-56.09%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.